StockNews.AI
TEM
StockNews.AI
189 days

Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24

1. Tempus to report Q4 and FY 2024 results on February 24, 2025. 2. Earnings conference call will feature CEO Eric Lefkofsky and CFO Jim Rogers. 3. Tempus utilizes AI in precision medicine with substantial multimodal data. 4. Earnings could influence investor sentiments around TEM through performance results. 5. The earnings report reflects the company's strategic direction and financial health.

6m saved
Insight
Article

FAQ

Why Bullish?

Upcoming earnings reports often lead to a positive market reaction, especially if expectations are met or exceeded. Similar instances have shown stocks often rise before earnings if early forecasts or guidance are promising.

How important is it?

The earnings report is critical for gauging Tempus' future trajectory and can shape investor decisions significantly, impacting TEM's stock price directly.

Why Short Term?

The immediate impact will be observed around the earnings release date. Companies typically see rapid stock price changes post-earnings announcements due to market adjustments.

Related Companies

TEM

Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025. The company will hold the earnings conference call at 4:30 p.m. ET. The company’s quarterly earnings will be released the same day.

The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus’ Investor Relations website. Alternatively, the call can be accessed via the following:

Conference ID: 9601821
Domestic Dial-in Number: (888) 596-4144
International Dial-in Number: (646) 968-2525
Live Webcast: https://edge.media-server.com/mmc/p/6qbep94p

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

Contacts

Tempus Communications
Erin Carron
Erin.carron@tempus.com

Tempus Investor Relations
Elizabeth Krutoholow
Elizabeth.krutoholow@tempus.com

Related News